Trump previously met with Ubl and chief executives of U.S. drugmakers Pfizer and Eli Lilly at his Mar-a-Lago estate in Florida in December, according to reports.

The offer may show employers how hard drug manufacturers will compete based on price, in at least some situations.

Bayer will seek shareholder approval to raise equity capital worth close to 35% of its outstanding shares over the next three ...

Many ex-special advisers are advising businesses in fields related to their government role, openDemocracy has found ...

The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy ... which has launched a campaign to ask the public to lobby their MPs to attend a meeting in December to raise ...

David Ricks, CEO of Eli Lilly (NYSE:LLY), Robert Davis ... Stephen Ubl, CEO of the pharma lobby group Pharmaceutical Research and Manufacturers of America (PhRMA), also attended the meeting.

The yearly pilgrimage in honor of St. Patrick’s Day came at a tense time for Ireland, with Irish Prime Minister Micheál ...

Lars Fruergaard Jørgensen might not be a household name, but his company’s drug is. And its success has thrust him — ...

In the wake of the raise, the startup announced an expansion to the scope and breadth of its strategic collaboration with Eli Lilly to research and develop ... Simon chaired the environment committee ...